stars 1 stars 2 stars 3

Problems with API solid state are often overlooked in drug development. Selecting a sub-optimal version, lack of polymorph control, and poor design of the API step can halt a clinical program or delay commercialisation. My SME expertise covers: Risk based development, version screening, polymorphism, hydration and solvation, API crystallisation development, downstream processing, filtration, washing and drying, particle size reduction, crystallization scale-up, quality by design, technical transfer, physical properties data interpretation.

API Particle Development Questions

API Particle Development is based in London, England.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users